{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T19:04:49Z","timestamp":1794855889675,"version":"4.9.1"},"reference-count":79,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2020,5,1]]},"DOI":"10.1001\/jamaophthalmol.2020.0155","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T11:40:36Z","timestamp":1586432436000},"page":"439","source":"Crossref","is-referenced-by-count":150,"title":["Trends in Antibiotic Resistance Among Ocular Microorganisms in the United States From 2009 to 2018"],"prefix":"10.1001","volume":"138","author":[{"given":"Penny A.","family":"Asbell","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, The University of Tennessee Health Science Center, Memphis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Sanfilippo","sequence":"additional","affiliation":[{"name":"Pharmaceutical Medical Affairs, Bausch\u2009+\u2009Lomb, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel F.","family":"Sahm","sequence":"additional","affiliation":[{"name":"International Health Management Associates Inc, Schaumburg, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heleen H.","family":"DeCory","sequence":"additional","affiliation":[{"name":"Pharmaceutical Medical Affairs, Bausch\u2009+\u2009Lomb, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"6","key":"eoi200006r1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1097\/ICO.0000000000000431","article-title":"Antibiotic resistance in the treatment of Staphylococcus aureus keratitis: a 20-year review.","volume":"34","author":"Chang","year":"2015","journal-title":"Cornea"},{"issue":"5","key":"eoi200006r2","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s00417-017-3608-y","article-title":"Microbial flora and resistance in ophthalmology: a review.","volume":"255","author":"Grzybowski","year":"2017","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"eoi200006r3","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/meajo.MEAJO_276_16","article-title":"Update on the epidemiology and antibiotic resistance of ocular infections.","volume":"24","author":"Miller","year":"2017","journal-title":"Middle East Afr J Ophthalmol"},{"issue":"12","key":"eoi200006r4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0208518","article-title":"Staphylococcus aureus from ocular and otolaryngology infections are frequently resistant to clinically important antibiotics and are associated with lineages of community and hospital origins.","volume":"13","author":"Wurster","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"eoi200006r5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00417-010-1426-6","article-title":"Shifting trends in in vitro antibiotic susceptibilities for common bacterial conjunctival isolates in the last decade at the New York Eye and Ear Infirmary.","volume":"249","author":"Adebayo","year":"2011","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"6","key":"eoi200006r6","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.ajo.2008.01.025","article-title":"Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates.","volume":"145","author":"Asbell","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"9","key":"eoi200006r7","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1089\/jop.2013.0040","article-title":"Antibiotic susceptibility of staphylococci isolates from patients with chronic conjunctivitis: including associated factors and clinical evaluation.","volume":"29","author":"Blanco","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"issue":"3","key":"eoi200006r8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.jaapos.2012.12.151","article-title":"Trends in ophthalmic manifestations of methicillin-resistant Staphylococcus aureus (MRSA) in a northern California pediatric population.","volume":"17","author":"Amato","year":"2013","journal-title":"J AAPOS"},{"issue":"2","key":"eoi200006r9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4103\/0301-4738.179721","article-title":"Multi-drug resistant Pseudomonas aeruginosa keratitis and its effective treatment with topical colistimethate.","volume":"64","author":"Chatterjee","year":"2016","journal-title":"Indian J Ophthalmol"},{"issue":"7","key":"eoi200006r10","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0161-6420(99)00717-4","article-title":"Ciprofloxacin-resistant Pseudomonas keratitis.","volume":"106","author":"Garg","year":"1999","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi200006r11","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/j.jcrs.2005.12.108","article-title":"Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery.","volume":"32","author":"Moshirfar","year":"2006","journal-title":"J Cataract Refract Surg"},{"issue":"1","key":"eoi200006r12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/jop.2011.0072","article-title":"Challenges in assessing microbial susceptibility and predicting clinical response to newer-generation fluoroquinolones.","volume":"28","author":"Segreti","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"issue":"9","key":"eoi200006r13","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1001\/archopht.121.9.1229","article-title":"Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis.","volume":"121","author":"Wilhelmus","year":"2003","journal-title":"Arch Ophthalmol"},{"issue":"8","key":"eoi200006r14","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1002\/phar.2012.32.issue-8","article-title":"Using rapid diagnostic tests to optimize antimicrobial selection in antimicrobial stewardship programs.","volume":"32","author":"Goff","year":"2012","journal-title":"Pharmacotherapy"},{"issue":"4","key":"eoi200006r19","doi-asserted-by":"publisher","first-page":"567.e3","DOI":"10.1016\/j.ajo.2011.03.010","article-title":"Monitoring antibiotic resistance in ocular microorganisms: results from the Antibiotic Resistance Monitoring in Ocular micRorganisms (ARMOR) 2009 Surveillance Study.","volume":"152","author":"Haas","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"eoi200006r20","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40123-018-0141-y","article-title":"Antibiotic resistance rates by geographic region among ocular pathogens collected during the ARMOR Surveillance Study.","volume":"7","author":"Asbell","year":"2018","journal-title":"Ophthalmol Ther"},{"issue":"12","key":"eoi200006r21","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/jamaophthalmol.2015.3888","article-title":"Antibiotic resistance among ocular pathogens in the United States: five-year results from the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study.","volume":"133","author":"Asbell","year":"2015","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"eoi200006r22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.17925\/USOR.2017.10.01.35","article-title":"Antibiotic resistance trends among ocular pathogens in the US\u2014cumulative results from the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study.","volume":"10","author":"Asbell","year":"2017","journal-title":"US Ophthalmic Rev"},{"key":"eoi200006r23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2147\/OPTO","article-title":"Antibiotic resistance among ocular pathogens: current trends from the ARMOR Surveillance Study (2009-2016).","volume":"11","author":"Thomas","year":"2019","journal-title":"Clin Optom (Auckl)"},{"issue":"2","key":"eoi200006r24","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1097\/INF.0000000000002206","article-title":"Antibiotic resistance among pediatric-sourced ocular pathogens: 8-year findings from the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study.","volume":"38","author":"Alter","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"eoi200006r25","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1016\/j.jcrs.2016.11.008","article-title":"Antibiotic susceptibility of bacterial pathogens isolated from the aqueous and vitreous humor in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study.","volume":"42","author":"Asbell","year":"2016","journal-title":"J Cataract Refract Surg"},{"issue":"10","key":"eoi200006r26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0205814","article-title":"Antibiotic resistance among bacterial conjunctival pathogens collected in the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) Surveillance Study.","volume":"13","author":"Asbell","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"eoi200006r41","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2307\/3001913","article-title":"Comparing individual means in the analysis of variance.","volume":"5","author":"Tukey","year":"1949","journal-title":"Biometrics"},{"issue":"3","key":"eoi200006r42","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2307\/3001775","article-title":"Tests for linear trends in proportions and frequencies.","volume":"11","author":"Armitage","year":"1955","journal-title":"Biometrics"},{"issue":"6","key":"eoi200006r43","doi-asserted-by":"publisher","first-page":"498","DOI":"10.4172\/2155-9570","article-title":"Microbial keratitis at an urban public hospital: a 10-year update.","volume":"6","author":"Truong","year":"2015","journal-title":"J Clin Exp Ophthalmol"},{"issue":"11","key":"eoi200006r44","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1136\/bjophthalmol-2016-310026","article-title":"Evolving risk factors and antibiotic sensitivity patterns for microbial keratitis at a large county hospital.","volume":"101","author":"Jin","year":"2017","journal-title":"Br J Ophthalmol"},{"key":"eoi200006r45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13756-017-0185-0","article-title":"Retrospective report of antimicrobial susceptibility observed in bacterial pathogens isolated from ocular samples at Mount Sinai Hospital, 2010 to 2015.","volume":"6","author":"Oydanich","year":"2017","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"eoi200006r46","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1097\/ICO.0000000000001417","article-title":"Bacterial keratitis: isolated organisms and antibiotic resistance patterns in San Francisco.","volume":"37","author":"Peng","year":"2018","journal-title":"Cornea"},{"issue":"4","key":"eoi200006r47","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1001\/archophthalmol.2011.45","article-title":"Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures.","volume":"129","author":"Fintelmann","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"eoi200006r48","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1086\/314056","article-title":"Mechanisms of action and resistance of older and newer fluoroquinolones.","volume":"31","author":"Hooper","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"2","key":"eoi200006r49","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1586\/eop.13.7","article-title":"Is antibiotic resistance a problem in the treatment of ophthalmic infections?","volume":"8","author":"Kowalski","year":"2013","journal-title":"Expert Rev Ophthalmol"},{"issue":"3","key":"eoi200006r50","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.ajo.2007.11.004","article-title":"Does in vitro susceptibility predict clinical outcome in bacterial keratitis?","volume":"145","author":"Chen","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"eoi200006r51","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1167\/iovs.09-3933","article-title":"Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis.","volume":"51","author":"Kaye","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"eoi200006r52","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1093\/cid\/cis189","article-title":"Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis.","volume":"54","author":"Lalitha","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9","key":"eoi200006r53","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1128\/JCM.00580-11","article-title":"The clinical predictive value (or lack thereof) of the results of in vitro antimicrobial susceptibility tests.","volume":"49","author":"Doern","year":"2011","journal-title":"J Clin Microbiol"},{"issue":"6","key":"eoi200006r54","doi-asserted-by":"publisher","first-page":"592.e1","DOI":"10.1016\/j.cmi.2015.01.028","article-title":"Correlation between clinical data and antibiotic resistance in coagulase-negative Staphylococcus species isolated from 68 patients with acute post-cataract endophthalmitis.","volume":"21","author":"Chiquet","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"eoi200006r55","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.2147\/OPTH","article-title":"Methicillin resistance of Staphylococcus species among health care and nonhealth care workers undergoing cataract surgery.","volume":"4","author":"Olson","year":"2010","journal-title":"Clin Ophthalmol"},{"issue":"1","key":"eoi200006r56","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1086\/657637","article-title":"Methicillin-resistant Staphylococcus aureus (MRSA) carriage in 10 nursing homes in Orange County, California.","volume":"32","author":"Reynolds","year":"2011","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"9","key":"eoi200006r57","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1086\/588716","article-title":"Epidemiology of Staphylococcus aureus colonization in nursing home residents.","volume":"46","author":"Mody","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"1","key":"eoi200006r58","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.diagmicrobio.2016.06.017","article-title":"Antimicrobial susceptibility patterns of community- and hospital-acquired methicillin-resistant Staphylococcus aureus from United States hospitals: results from the AWARE Ceftaroline Surveillance Program (2012-2014).","volume":"86","author":"Sader","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"eoi200006r59","doi-asserted-by":"publisher","first-page":"558","DOI":"10.2174\/1381612822666161129150628","article-title":"Dropless cataract surgery: an overview.","volume":"23","author":"Lindstrom","year":"2017","journal-title":"Curr Pharm Des"},{"issue":"3","key":"eoi200006r60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/IIO.0000000000000122","article-title":"Cataract drug delivery systems (dropless vs. nondropless cataract surgery).","volume":"56","author":"Rhee","year":"2016","journal-title":"Int Ophthalmol Clin"},{"key":"eoi200006r61","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ajoc.2018.12.003","article-title":"Endophthalmitis following cataract surgery and intracameral antibiotic: moxifloxacin resistant Staphylococcus epidermidis.","volume":"13","author":"Chang","year":"2018","journal-title":"Am J Ophthalmol Case Rep"},{"issue":"12","key":"eoi200006r62","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1016\/j.jcrs.2018.07.055","article-title":"Acute-onset postoperative endophthalmitis after cataract surgery and transzonular intravitreal triamcinolone-moxifloxacin.","volume":"44","author":"Kishore","year":"2018","journal-title":"J Cataract Refract Surg"},{"issue":"2","key":"eoi200006r63","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1007\/s40135-018-0174-3","article-title":"The safety, efficacy, and potential complications of intracameral antibiotics.","volume":"6","author":"Tye","year":"2018","journal-title":"Curr Ophthalmol Rep"},{"key":"eoi200006r64","doi-asserted-by":"crossref","DOI":"10.1177\/1120672119852505","article-title":"Endophthalmitis after dropless (Tri-Moxi injection) cataract surgery.","author":"Ng","year":"2019","journal-title":"Eur J Ophthalmol"},{"issue":"5","key":"eoi200006r65","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1309\/AJCPQ46ZPQXVHHNC","article-title":"Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in northeastern Ohio.","volume":"132","author":"Delorme","year":"2009","journal-title":"Am J Clin Pathol"},{"issue":"12","key":"eoi200006r66","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1099\/jmm.0.000635","article-title":"Patient age as a factor of antibiotic resistance in methicillin-resistant Staphylococcus aureus.","volume":"66","author":"Garcia","year":"2017","journal-title":"J Med Microbiol"},{"issue":"4","key":"eoi200006r68","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.ophtha.2012.10.001","article-title":"Identification of causative pathogens in eyes with bacterial conjunctivitis by bacterial cell count and microbiota analysis.","volume":"120","author":"Aoki","year":"2013","journal-title":"Ophthalmology"},{"issue":"3","key":"eoi200006r69","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1136\/bjo.2005.084095","article-title":"Polymicrobial infection and the eye.","volume":"90","author":"Tuft","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"eoi200006r70","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0178254","article-title":"Effect of meteorological factors and geographic location on methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci colonization in the US.","volume":"12","author":"Blanco","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"eoi200006r71","doi-asserted-by":"publisher","first-page":"e01555","DOI":"10.1128\/AAC.02383-17","article-title":"In vitro activities of ceftaroline and comparators against Streptococcus pneumoniae isolates from US hospitals: results from seven years of the AWARE Surveillance Program (2010 to 2016).","volume":"62","author":"Pfaller","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"eoi200006r72","doi-asserted-by":"publisher","first-page":"e01043","DOI":"10.1128\/AAC.01043-17","article-title":"Antimicrobial susceptibility trends among Staphylococcus aureus isolates from US hospitals: results from 7 years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016.","volume":"61","author":"Sader","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"eoi200006r73","doi-asserted-by":"publisher","first-page":"e00609","DOI":"10.1128\/AAC.00609-17","article-title":"Five-year summary of in vitro activity and resistance mechanisms of linezolid against clinically important gram-positive cocci in the United States from the LEADER Surveillance Program (2011 to 2015).","volume":"61","author":"Pfaller","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"4","key":"eoi200006r74","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1128\/AAC.02803-15","article-title":"Linezolid surveillance results for the United States (LEADER Surveillance Program 2014).","volume":"60","author":"Flamm","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"eoi200006r75","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1186\/s13756-018-0441-y","article-title":"Antimicrobial susceptibility among gram-positive and gram-negative blood-borne pathogens collected between 2012-2016 as part of the Tigecycline Evaluation and Surveillance Trial.","volume":"7","author":"Zhang","year":"2018","journal-title":"Antimicrob Resist Infect Control"},{"issue":"1","key":"eoi200006r76","doi-asserted-by":"publisher","first-page":"e00310","DOI":"10.1128\/mSphere.00310-16","article-title":"Global assessment of the activity of tigecycline against multidrug-resistant gram-negative pathogens between 2004 and 2014 as part of the Tigecycline Evaluation and Surveillance Trial.","volume":"2","author":"Giammanco","year":"2017","journal-title":"mSphere"},{"key":"eoi200006r77","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1093\/ofid\/ofy270","article-title":"Twenty-year trends in antimicrobial susceptibilities among Staphylococcus aureus from the SENTRY Antimicrobial Surveillance Program.","volume":"6","author":"Diekema","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"eoi200006r78","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1093\/ofid\/ofy263","article-title":"Antimicrobial susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific Region: results from 20 years of the SENTRY Antimicrobial Surveillance Program (1997-2016).","volume":"6","author":"Sader","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"eoi200006r79","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.1093\/ofid\/ofy343","article-title":"Geographic and temporal patterns of antimicrobial resistance in Pseudomonas aeruginosa over 20 years from the SENTRY Antimicrobial Surveillance Program, 1997-2016.","volume":"6","author":"Shortridge","year":"2019","journal-title":"Open Forum Infect Dis"},{"key":"eoi200006r17","author":"Asbell"},{"key":"eoi200006r18","author":"Asbell"},{"key":"eoi200006r27","author":"Clinical and Laboratory Standards Institute","year":"2009"},{"key":"eoi200006r28","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"eoi200006r29","author":"Clinical and Laboratory Standards Institute","year":"2015"},{"key":"eoi200006r30","author":"Clinical and Laboratory Standards Institute","year":"2018"},{"key":"eoi200006r31","author":"Clinical and Laboratory Standards Institute","year":"2009"},{"key":"eoi200006r32","author":"Clinical and Laboratory Standards Institute","year":"2010"},{"key":"eoi200006r33","author":"Clinical and Laboratory Standards Institute","year":"2011"},{"key":"eoi200006r34","author":"Clinical and Laboratory Standards Institute","year":"2012"},{"key":"eoi200006r35","author":"Clinical and Laboratory Standards Institute","year":"2013"},{"key":"eoi200006r36","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"key":"eoi200006r37","author":"Clinical and Laboratory Standards Institute","year":"2015"},{"key":"eoi200006r38","author":"Clinical and Laboratory Standards Institute","year":"2016"},{"key":"eoi200006r39","author":"Clinical and Laboratory Standards Institute","year":"2017"},{"key":"eoi200006r40","author":"Clinical and Laboratory Standards Institute","year":"2018"},{"key":"eoi200006r67","author":"Blondeau","year":"2019"},{"key":"eoi200006r15","unstructured":"American Academy of Ophthalmology. Bacterial keratitis preferred practice pattern\u20132018. https:\/\/www.aao.org\/preferred-practice-pattern\/bacterial-keratitis-ppp-2018. Published November 2018. Accessed March 5, 2019."},{"key":"eoi200006r16","unstructured":"American Academy of Ophthalmology. Conjunctivitis preferred practice pattern\u20132018. https:\/\/www.aao.org\/preferred-practice-pattern\/conjunctivitis-ppp-2018. Published November 2018. Accessed March 5, 2019."}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2763805\/jamaophthalmology_asbell_2020_oi_200006.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T14:52:59Z","timestamp":1722696779000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2763805"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,1]]},"references-count":79,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2020.0155","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5,1]]}}}